JNJ peer analysis
Johnson & Johnson (JNJ) against its competitors: price, today's move, 1-year return and market value side by side.
JNJ and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ABBV AbbVie | $288.81 | -2.06% | 26.58% | $521.11B |
| AMGN Amgen | $466.45 | 0.09% | 59.79% | $251.94B |
| AZN AstraZeneca | $186.49 | -0.09% | 13.09% | $289.48B |
| BMY Bristol-Myers Squibb | $62.56 | 0.14% | 37.29% | $127.71B |
| GILD Gilead | $170.21 | -0.28% | 43.44% | $211.70B |
| GSK GSK | $49.04 | -0.95% | 4.38% | $99.19B |
| MRK Merck | $148.66 | -0.58% | 72.40% | $368.89B |
| NVS Novartis | $160.94 | 0.09% | 31.18% | $303.67B |
| PFE Pfizer | $30.64 | 0.39% | 25.61% | $173.95B |
| SNY Sanofi | $45.25 | 2.05% | -11.35% | $106.24B |
| JNJ Johnson & Johnson | $269.30 | -1.43% | 42.35% | $657.68B |
- JNJ's peers: ABBV (AbbVie), AMGN (Amgen), AZN (AstraZeneca), BMY (Bristol-Myers Squibb), GILD (Gilead), GSK (GSK), MRK (Merck), NVS (Novartis).
Updated 2026-11-02 17:56 UTC